87 related articles for article (PubMed ID: 3061036)
1. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Alexander K
Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
[No Abstract] [Full Text] [Related]
2. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
[No Abstract] [Full Text] [Related]
3. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
Caspary L; Creutzig A; Radeke U; Specht S; Alexander K
Biomed Biochim Acta; 1988; 47(10-11):S307-10. PubMed ID: 3073766
[TBL] [Abstract][Full Text] [Related]
4. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
Rudofsky G
Wien Klin Wochenschr; 1988 Jul; 100(14):484-8. PubMed ID: 3062906
[TBL] [Abstract][Full Text] [Related]
5. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
6. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
Dé P; Hepp W
Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
[No Abstract] [Full Text] [Related]
7. Intermittent intra-arterial prostaglandin E1 therapy of severe claudication.
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1987; 17():44-6. PubMed ID: 3470966
[No Abstract] [Full Text] [Related]
8. Intra-arterial perfusion with prostaglandin E1 in patients with intermittent claudication.
Rudofsky G; Altenhoff B; Meyer P; Lohmann A
Vasa Suppl; 1987; 17():47-51. PubMed ID: 3551153
[No Abstract] [Full Text] [Related]
9. [Results of intra-arterial administration of PGE1 prostaglandin].
Ciostek P; Kostewicz W; Górski G
Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
[TBL] [Abstract][Full Text] [Related]
10. [Effect of prostaglandin E1 on neutrophilic granulocytes of patients with intermittent claudication].
Weiss T; Neumann FJ; Mollenhauer J; Haupt HM; Diehm C
Vasa Suppl; 1991; 32():345-6. PubMed ID: 1771529
[No Abstract] [Full Text] [Related]
11. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
12. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
[TBL] [Abstract][Full Text] [Related]
13. Treatment of intermittent claudication with inositol nicotinate.
Head A
Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149
[No Abstract] [Full Text] [Related]
14. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1.
Heider P; Wildgruber M; Wolf O; Schuster T; Lutzenberger W; Berger H; Eckstein HH
Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):23-30. PubMed ID: 18832042
[TBL] [Abstract][Full Text] [Related]
15. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
16. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
17. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
Kriessmann A; Neiss A
Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
[No Abstract] [Full Text] [Related]
19. [Does infusion therapy in trained patients with intermittent claudication have advantages?].
Weiss T; Wilhelm C; Hübsch-Müller C; Hsu E; Diehm C
Vasa Suppl; 1990; 30():142-5. PubMed ID: 2075567
[No Abstract] [Full Text] [Related]
20. Treatment of claudication with dipyridamole and aspirin.
Libretti A; Catalano M
Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
